Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	76.32	59.82	175.53	20.53	86.51	24.93
Short-Term Investments	182.86	268.31	71	205.91	39	20
Cash & Short-Term Investments	259.18	328.13	246.53	226.44	125.51	44.93
Cash Growth	-26.93%	33.10%	8.87%	80.42%	179.34%	23.96%
Prepaid Expenses	9.41	6.51	4.41	1.25	1.45	1.4
Restricted Cash	-	-	-	-	0.12	-
Total Current Assets	268.59	334.64	250.94	227.69	127.08	46.33
Property, Plant & Equipment	4.55	5.11	0.36	0.95	0.39	0.97
Other Long-Term Assets	8.79	2.61	3.36	2	0.05	0.17
Total Assets	281.92	342.36	254.67	230.63	127.51	47.46
Accounts Payable	0.74	4.32	1.51	0.79	1.56	1.54
Accrued Expenses	15.91	13.43	9.71	7.69	3.28	4.2
Current Portion of Leases	1.4	1.38	0.33	0.58	0.37	0.65
Total Current Liabilities	18.04	19.13	11.55	9.06	5.2	6.39
Long-Term Leases	3.37	3.97	-	0.36	-	0.4
Total Liabilities	21.41	23.1	11.55	9.42	5.2	6.79
Common Stock	0.06	0.06	0.04	0.03	0.01	0
Additional Paid-In Capital	906.7	898.51	728.29	632.51	481.71	301.56
Retained Earnings	-741.56	-674.79	-580.53	-507.64	-455.81	-260.9
Comprehensive Income & Other	-0.02	0.16	-	-0.08	-	-
Total Common Equity	165.19	223.94	147.79	124.82	25.91	40.67
Shareholders' Equity	260.51	319.26	243.12	221.22	122.31	40.67
Total Liabilities & Equity	281.92	342.36	254.67	230.63	127.51	47.46
Total Debt	4.77	5.35	0.33	0.94	0.37	1.05
Net Cash (Debt)	254.41	322.78	246.2	225.5	125.14	43.88
Net Cash Growth	-27.08%	31.10%	9.18%	80.19%	185.17%	29.10%
Net Cash Per Share	4.39	5.75	8.17	15.42	14.02	14.35
Filing Date Shares Outstanding	56.43	56.43	54.9	27.99	13.02	3.9
Total Common Shares Outstanding	56.43	56.43	41.03	27.5	13.02	3.35
Working Capital	250.54	315.51	239.39	218.63	121.87	39.94
Book Value Per Share	2.93	3.97	3.60	4.54	1.99	12.15
Tangible Book Value	165.19	223.94	147.79	124.82	25.91	40.67
Tangible Book Value Per Share	2.93	3.97	3.60	4.54	1.99	12.15

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q